Clinical Trial: A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)

U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06814132) titled 'A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)' on Feb. 03.

Brief Summary: The goal of the study is to learn what happens to levels of MK-5684 in people with severe renal impairment and end-stage renal disease versus a healthy person's body over time. Researchers will compare what happens to MK-5684 after hemodialysis in people with severe renal impairment and end-stage renal disease versus healthy people.

Study Start Date: March 14

Study Type: INTERVENTIONAL

Condition: Kidney Failure, Chronic End-Stage Kidney Disease Renal Fai...